Allison is a neuroscientist with bachelor’s degrees in Psychology and Biology and a Ph.D. in Cellular and Molecular Biology from the University of Denver. The main focus of her doctoral research was characterizing complex patient outcomes following brain injury, with a particular emphasis on the combined effects of infection and injury on long-term brain health and neurodegenerative disease risk. Utilizing advanced statistical modeling, computational techniques and integrative omics approaches, she analyzed diverse biological datasets to uncover potential mechanisms underlying clinical trajectories. She also contributed to a Phase 2A clinical trial for ALS and gained extensive laboratory experience, including work with exosome isolation, cell culture, electron and confocal microscopy, and biomarker discovery. In her current role at the Wyss Institute, Allison combines her passion for translational research with her computational and biological expertise to discover new anesthetic drugs and explore the neural and molecular mechanisms of anesthesia.